Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Tue Apr 01 20:39:03 GMT 2025
by
admin
on
Tue Apr 01 20:39:03 GMT 2025
|
| Protein Sub Type | |
| Sequence Type | COMPLETE |
| Record UNII |
31V857ZRPY
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
LOINC |
40601-7
Created by
admin on Tue Apr 01 20:39:03 GMT 2025 , Edited by admin on Tue Apr 01 20:39:03 GMT 2025
|
||
|
FDA ORPHAN DRUG |
172803
Created by
admin on Tue Apr 01 20:39:03 GMT 2025 , Edited by admin on Tue Apr 01 20:39:03 GMT 2025
|
||
|
LOINC |
48416-2
Created by
admin on Tue Apr 01 20:39:03 GMT 2025 , Edited by admin on Tue Apr 01 20:39:03 GMT 2025
|
||
|
LOINC |
2685-6
Created by
admin on Tue Apr 01 20:39:03 GMT 2025 , Edited by admin on Tue Apr 01 20:39:03 GMT 2025
|
||
|
EU-Orphan Drug |
EU/3/03/138
Created by
admin on Tue Apr 01 20:39:03 GMT 2025 , Edited by admin on Tue Apr 01 20:39:03 GMT 2025
|
||
|
LOINC |
33781-6
Created by
admin on Tue Apr 01 20:39:03 GMT 2025 , Edited by admin on Tue Apr 01 20:39:03 GMT 2025
|
||
|
LOINC |
40600-9
Created by
admin on Tue Apr 01 20:39:03 GMT 2025 , Edited by admin on Tue Apr 01 20:39:03 GMT 2025
|
||
|
FDA ORPHAN DRUG |
173103
Created by
admin on Tue Apr 01 20:39:03 GMT 2025 , Edited by admin on Tue Apr 01 20:39:03 GMT 2025
|
||
|
LOINC |
76688-1
Created by
admin on Tue Apr 01 20:39:03 GMT 2025 , Edited by admin on Tue Apr 01 20:39:03 GMT 2025
|
||
|
LOINC |
2684-9
Created by
admin on Tue Apr 01 20:39:03 GMT 2025 , Edited by admin on Tue Apr 01 20:39:03 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000177289
Created by
admin on Tue Apr 01 20:39:03 GMT 2025 , Edited by admin on Tue Apr 01 20:39:03 GMT 2025
|
PRIMARY | |||
|
P02763
Created by
admin on Tue Apr 01 20:39:03 GMT 2025 , Edited by admin on Tue Apr 01 20:39:03 GMT 2025
|
PRIMARY | |||
|
31V857ZRPY
Created by
admin on Tue Apr 01 20:39:03 GMT 2025 , Edited by admin on Tue Apr 01 20:39:03 GMT 2025
|
PRIMARY | |||
|
OROSOMUCOID
Created by
admin on Tue Apr 01 20:39:03 GMT 2025 , Edited by admin on Tue Apr 01 20:39:03 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_5 | 1_147 |
| 1_72 | 1_165 |
| Glycosylation Type | HUMAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_15 |
| N | 1_38 |
| N | 1_54 |
| N | 1_75 |
| N | 1_85 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
LIGAND->BINDING PROTEIN |
chlorpromazine displayed an approximately 1:1 [drug:AGP] binding stoichiometry; DETERMINED BY ITC
BINDING
Kd
|
||
|
LIGAND->BINDER | |||
|
|
LIGAND->BINDER | |||
|
LIGAND->BINDING PROTEIN |
Amitriptyline displayed an approximately 2:1 [drug:AGP] binding stoichiometry; DETERMINED BY ITC
BINDING
Kd
|
||
|
LIGAND->BINDER |
BINDING
|
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| AMINO ACID SUBSTITUTION | [1_1] | GLUTAMINE | PIDOLIC ACID | SZB83O1W42 |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:WEIGHT AVERAGE(SDS PAGE) | CHEMICAL |
|
||||
| Molecular Formula | CHEMICAL |
|